Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 386748, "name": "Biofil Chemicals", "stock_name": "Biofil Chemicals", "full_name": "Biofil Chemicals & Pharmaceuticals Ltd", "name_url": "stocks-analysis/biofil-chemicals", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "36.39", "chg": -0.13, "chgp": "-0.36%", "dir": -1, "prev_price": "36.52", "mcapval": "61.00 Cr", "mcap": "Micro Cap", "scripcode": 524396, "symbol": "BIOFILCHEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE829A01014", "curr_date": "Jun 24, 12:04 PM", "curr_time": "12:07 PM", "last_traded_at": "Jun 24, 12:04 PM IST", "bse_nse_vol": "10.45 k", "exc_status": "Active", "traded_date": "Jun 24, 2026", "traded_date_str": "2026 06 24", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-4058701", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_mojoScore_4058701.png", "date": "2026-06-17 10:11:42", "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Biofil Chemicals Gains 1.17%: Technical and Valuation Shifts Drive Weekly Movement", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-gains-117-technical-and-valuation-shifts-drive-weekly-movement-4052941", "imagepath": "", "date": "2026-06-14 11:01:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Q4 FY26 results reveal exceptional income masking operational weakness</p>\n <p><strong>1 June:</strong> MarketsMOJO upgrades rating to Sell on improved technicals and valuation</p>\n <p><strong>5 June:</strong> Stock rallies 3.11% on strong volume, closing at Rs.35.52</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.35.11</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.35.52</div><div class=\"stat-change positive\">+1.17%</div></di..." }, { "title": "Are Biofil Chemicals & Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-biofil-chemicals-pharmaceuticals-ltd-latest-results-good-or-bad-4028070", "imagepath": "", "date": "2026-06-01 19:26:31", "description": "Biofil Chemicals & Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported net sales of ₹7.57 crores, reflecting a significant quarter-on-quarter growth of 780.23% from the previous quarter's ₹0.86 crores. However, this surge is contrasted by a year-on-year decline of 9.34%, indicating ongoing demand challenges despite the apparent recovery.\n\nNet profit for the quarter stood at ₹0.21 crores, which is a 162.50% increase compared to the previous quarter, and a 5.00% increase year-on-year. While this uptick in profit may seem positive, it is essential to note that the overall operational performance remains inconsistent. The operating margin decreased to 5.68% from 11.63% in the prior quarter, suggesting rising input costs or unfavorable product mix despite higher sales.\n\nThe volatility in revenue is a critical concern, with sales flu..." }, { "title": "Biofil Chemicals Q4 FY26: Exceptional Income Masks Operational Weakness", "link": "https://www.marketsmojo.com/news/result-analysis/biofil-chemicals-q4-fy26-exceptional-income-masks-operational-weakness-4026683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_quaterlyResult_4026683.png", "date": "2026-06-01 10:51:39", "description": "Biofil Chemicals & Pharmaceuticals Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹57.00 crores, reported net profit of ₹0.21 crores in Q4 FY26 (Mar'26), marking a modest 5.00% increase year-on-year but a substantial 162.50% surge quarter-on-quarter. However, this apparent profitability improvement conceals deeper operational challenges, as the company's core business performance remains under significant pressure with volatile revenue patterns and contracting margins." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-upgraded-to-sell-on-improved-technicals-and-valuation-4025567", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiofilChemicals_mojoScore_4025567.png", "date": "2026-06-01 08:15:54", "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook and valuation metrics despite ongoing fundamental challenges. The upgrade, effective from 29 May 2026, is driven primarily by improved technical indicators and a more attractive valuation grade, while financial trends and quality scores remain subdued." }, { "title": "Biofil Chemicals Surges 11.64% Amid Valuation Shifts and Mixed Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-surges-1164-amid-valuation-shifts-and-mixed-fundamentals-4023581", "imagepath": "", "date": "2026-05-30 17:16:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock dips 0.92% to Rs.31.16 despite Sensex rally</p>\n <p><strong>26 May:</strong> Upper circuit hit with 19.99% gain, closing at Rs.37.09</p>\n <p><strong>27 May:</strong> Downgrade to Strong Sell announced amid mixed technicals</p>\n <p><strong>29 May:</strong> Week closes at Rs.35.11, down 3.14% on final trading day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.31.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-fundamentals-4015952", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiofilChemicals_mojoScore_4015952.png", "date": "2026-05-27 08:19:51", "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Strong Sell, driven primarily by shifts in technical indicators and valuation metrics. Despite persistent challenges in financial trends and quality fundamentals, the recent market performance and valuation adjustments have prompted this reassessment, signalling cautious investor sentiment amid mixed signals." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4015541", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiofilChemicals_valuationdot_4015541.png", "date": "2026-05-27 08:00:32", "description": "Biofil Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging performance relative to the broader market. This change, driven primarily by adjustments in its price-to-earnings and price-to-book ratios, offers investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-to-upper-circuit-on-robust-buying-pressure-4013675", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiofilChemicals_stocks_hitting_upper_circuit_4013675.png", "date": "2026-05-26 11:00:09", "description": "At Rs 37.82, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 19.99% on 26 May 2026, with buyers queuing and no sellers willing to part with shares." } ], "total": 187, "sid": "386748", "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "01-Jun-2026", "details": "Submission of publication of Audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015", "source": "BSE" }, { "caption": "Audited Financial Result For The Financial Year Ended 31.03.2026", "datetime": "30-May-2026", "details": "Audited Financial Result for the Financial Year ended 31.03.2026", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 30Th May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.", "datetime": "30-May-2026", "details": "Outcome of Board Meeting held on Saturday 30th May 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Stock dips 0.92% to Rs.31.16 despite Sensex rally

26 May: Upper circuit hit with 19.99% gain, closing at Rs.37.09

27 May: Downgrade to Strong Sell announced amid mixed technicals

29 May: Week closes at Rs.35.11, down 3.14% on final trading day

Week Open

Rs.31.45

Week Close

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals

2026-05-27 08:19:51

Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Strong Sell, driven primarily by shifts in technical indicators and valuation metrics. Despite persistent challenges in financial trends and quality fundamentals, the recent market performance and valuation adjustments have prompted this reassessment, signalling cautious investor sentiment amid mixed signals.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-05-27 08:00:32

Biofil Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging performance relative to the broader market. This change, driven primarily by adjustments in its price-to-earnings and price-to-book ratios, offers investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent

2026-05-26 11:00:09

At Rs 37.82, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 19.99% on 26 May 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article